SE9700661D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9700661D0
SE9700661D0 SE9700661A SE9700661A SE9700661D0 SE 9700661 D0 SE9700661 D0 SE 9700661D0 SE 9700661 A SE9700661 A SE 9700661A SE 9700661 A SE9700661 A SE 9700661A SE 9700661 D0 SE9700661 D0 SE 9700661D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
substituted
formula
treatment
Prior art date
Application number
SE9700661A
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9700661A priority Critical patent/SE9700661D0/sv
Publication of SE9700661D0 publication Critical patent/SE9700661D0/sv
Priority to ZA981134A priority patent/ZA981134B/xx
Priority to ARP980100614A priority patent/AR011134A1/es
Priority to HU0000720A priority patent/HUP0000720A3/hu
Priority to TR1999/02060T priority patent/TR199902060T2/xx
Priority to US09/043,040 priority patent/US6265415B1/en
Priority to AT98907306T priority patent/ATE218569T1/de
Priority to SK1099-99A priority patent/SK283903B6/sk
Priority to BR9807457-1A priority patent/BR9807457A/pt
Priority to RU99120178/04A priority patent/RU2193036C2/ru
Priority to EEP199900367A priority patent/EE04016B1/xx
Priority to PT98907306T priority patent/PT971920E/pt
Priority to DE69805787T priority patent/DE69805787T2/de
Priority to JP53654998A priority patent/JP2001512477A/ja
Priority to SI9830239T priority patent/SI0971920T1/xx
Priority to ES98907306T priority patent/ES2178169T3/es
Priority to PCT/SE1998/000275 priority patent/WO1998037080A1/en
Priority to CZ19993014A priority patent/CZ291681B6/cs
Priority to EP98907306A priority patent/EP0971920B1/en
Priority to UA99084654A priority patent/UA64741C2/uk
Priority to CN98802784A priority patent/CN1100056C/zh
Priority to IDW990903A priority patent/ID22218A/id
Priority to IL13112298A priority patent/IL131122A0/xx
Priority to TW087102208A priority patent/TW568907B/zh
Priority to NZ336878A priority patent/NZ336878A/en
Priority to CA002280008A priority patent/CA2280008A1/en
Priority to KR1019997007685A priority patent/KR20000075622A/ko
Priority to DK98907306T priority patent/DK0971920T3/da
Priority to AU63147/98A priority patent/AU723389B2/en
Priority to PL98335485A priority patent/PL190379B1/pl
Priority to MYPI98000774A priority patent/MY118822A/en
Priority to IS5148A priority patent/IS1901B/is
Priority to MXPA/A/1999/007650A priority patent/MXPA99007650A/xx
Priority to NO19994078A priority patent/NO313009B1/no
Priority to HK00103720A priority patent/HK1024248A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SE9700661A 1997-02-25 1997-02-25 New compounds SE9700661D0 (sv)

Priority Applications (35)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
ZA981134A ZA981134B (en) 1997-02-25 1998-02-11 Compounds for inhibition of gastric acid secretion
ARP980100614A AR011134A1 (es) 1997-02-25 1998-02-11 Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento
PL98335485A PL190379B1 (pl) 1997-02-25 1998-02-17 Pochodne imidazo [1,2-a] pirydyny, sposób ich wytwarzania, ich zastosowanie oraz środek farmaceutyczny
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
EP98907306A EP0971920B1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
US09/043,040 US6265415B1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
AT98907306T ATE218569T1 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion
SK1099-99A SK283903B6 (sk) 1997-02-25 1998-02-17 Substituované imidazopyridínové deriváty na inhibíciu sekrécie žalúdočnej kyseliny, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie
BR9807457-1A BR9807457A (pt) 1997-02-25 1998-02-17 Composto, sal de hidrocloreto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para a inibição da secreção de ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais e para o tratamento ou profilaxia de condições que envolvem infecção por helicobacter pylori da mucosa gástrica humana.
RU99120178/04A RU2193036C2 (ru) 1997-02-25 1998-02-17 Производные имидазо[1,2-а]пиридина, способы их получения, фармацевтический препарат на их основе, способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которые вовлечено инфицирование h.pylori
EEP199900367A EE04016B1 (et) 1997-02-25 1998-02-17 Ühendid maohappesekretsiooni inhibeerimiseks
PT98907306T PT971920E (pt) 1997-02-25 1998-02-17 Compostos para a inibicao da secrecao de acido gastrico
DE69805787T DE69805787T2 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion
JP53654998A JP2001512477A (ja) 1997-02-25 1998-02-17 胃酸分泌を阻止するための化合物
SI9830239T SI0971920T1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
ES98907306T ES2178169T3 (es) 1997-02-25 1998-02-17 Compuestos para la inhibicion de la secrecion de acido gastrico.
HU0000720A HUP0000720A3 (en) 1997-02-25 1998-02-17 Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use
CZ19993014A CZ291681B6 (cs) 1997-02-25 1998-02-17 Imidazopyridinový derivát, způsob jeho přípravy a použití a farmaceutický prostředek s jeho obsahem
TR1999/02060T TR199902060T2 (xx) 1997-02-25 1998-02-17 Gastrik asit salg�lanmas�n�n inhibisyonu i�in bile�ikler.
UA99084654A UA64741C2 (uk) 1997-02-25 1998-02-17 Заміщені похідні імідазопіридину, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі (варіанти), спосіб пригнічення секреції шлункової кислоти або лікування шлунково-кишкових запалювальних захворювань та спосіб лікування або профілактики станів, пов'язаних з інфікуванням helicobacter pylori слизової оболонки шлунку
CN98802784A CN1100056C (zh) 1997-02-25 1998-02-17 抑制胃酸分泌的化合物
IDW990903A ID22218A (id) 1997-02-25 1998-02-17 Senyawa-senyawa penghambat sekresi asam lambung
IL13112298A IL131122A0 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
TW087102208A TW568907B (en) 1997-02-25 1998-02-17 Imidazo pyridine derivatives for inhibition of gastric acid secretion
NZ336878A NZ336878A (en) 1997-02-25 1998-02-17 Imidazo pyridine compounds for inhibition of gastric acid secretion
CA002280008A CA2280008A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
KR1019997007685A KR20000075622A (ko) 1997-02-25 1998-02-17 위산 분비 억제용 화합물
DK98907306T DK0971920T3 (da) 1997-02-25 1998-02-17 Forbindelser til inhibition af mavesyresekretion
AU63147/98A AU723389B2 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion
MYPI98000774A MY118822A (en) 1997-02-25 1998-02-23 Compounds for inhibition of gastric acid secretion
IS5148A IS1901B (is) 1997-02-25 1999-08-05 Efnasambönd til að hindra magasýruseytrun
MXPA/A/1999/007650A MXPA99007650A (en) 1997-02-25 1999-08-18 Compounds for inhibition of gastric acid secretion
NO19994078A NO313009B1 (no) 1997-02-25 1999-08-24 Forbindelser for inhibering av mavesyresekresjon, farmasöytisk formulering inneholdende slike forbindelser, deresanvendelse og fremgangsmåte for deres fremstilling
HK00103720A HK1024248A1 (en) 1997-02-25 2000-06-20 Compounds for inhibition of gastric acid secretion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds

Publications (1)

Publication Number Publication Date
SE9700661D0 true SE9700661D0 (sv) 1997-02-25

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds

Country Status (33)

Country Link
US (1) US6265415B1 (sv)
EP (1) EP0971920B1 (sv)
JP (1) JP2001512477A (sv)
KR (1) KR20000075622A (sv)
CN (1) CN1100056C (sv)
AR (1) AR011134A1 (sv)
AT (1) ATE218569T1 (sv)
AU (1) AU723389B2 (sv)
BR (1) BR9807457A (sv)
CA (1) CA2280008A1 (sv)
CZ (1) CZ291681B6 (sv)
DE (1) DE69805787T2 (sv)
DK (1) DK0971920T3 (sv)
EE (1) EE04016B1 (sv)
ES (1) ES2178169T3 (sv)
HK (1) HK1024248A1 (sv)
HU (1) HUP0000720A3 (sv)
ID (1) ID22218A (sv)
IL (1) IL131122A0 (sv)
IS (1) IS1901B (sv)
MY (1) MY118822A (sv)
NO (1) NO313009B1 (sv)
NZ (1) NZ336878A (sv)
PL (1) PL190379B1 (sv)
PT (1) PT971920E (sv)
RU (1) RU2193036C2 (sv)
SE (1) SE9700661D0 (sv)
SK (1) SK283903B6 (sv)
TR (1) TR199902060T2 (sv)
TW (1) TW568907B (sv)
UA (1) UA64741C2 (sv)
WO (1) WO1998037080A1 (sv)
ZA (1) ZA981134B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
CA2194236C (en) * 1994-07-01 2009-02-24 Dermot Kelleher Helicobacter proteins and vaccines
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
TWI351405B (en) 2002-09-19 2011-11-01 Schering Corp Novel imidazopyridines as cyclin dependent kinase
OA13151A (en) * 2003-02-26 2006-12-13 Sugen Inc Aminoheteroaryl compounds as protein kinase inhibitors.
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
WO2005026164A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
KR20070053231A (ko) * 2004-07-28 2007-05-23 다케다 야쿠힌 고교 가부시키가이샤 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도
ATE518858T1 (de) 2004-09-03 2011-08-15 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
CA2579127C (en) 2004-09-03 2011-08-02 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
DK1861074T3 (da) * 2005-03-16 2013-07-29 Takeda Gmbh Smagsmaskeret doseringsform indeholdende roflumilast
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体
ES2402419T3 (es) 2005-12-05 2013-05-03 Pfizer Products Inc. Polimorfos de un inhibidor de C-MET/HGFR
AU2006323027B2 (en) 2005-12-05 2012-08-02 Pfizer Products Inc Method of treating abnormal cell growth
RU2608611C2 (ru) * 2009-11-05 2017-01-23 Юниверсити Оф Нотр Дам Дю Лак СОЕДИНЕНИЯ ИМИДАЗО[1,2-а] ПИРИДИНА, ИХ СИНТЕЗ И СПОСОБЫ ПРИМЕНЕНИЯ
EA201391769A1 (ru) 2011-05-30 2014-04-30 Астеллас Фарма Инк. Имидазопиридиновые соединения
JP6056872B2 (ja) * 2012-11-30 2017-01-11 アステラス製薬株式会社 イミダゾピリジン化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
EP0971920B1 (en) 2002-06-05
WO1998037080A1 (en) 1998-08-27
MX9907650A (es) 2002-12-13
EE9900367A (et) 2000-04-17
PL190379B1 (pl) 2005-12-30
CN1100056C (zh) 2003-01-29
EP0971920A1 (en) 2000-01-19
TR199902060T2 (xx) 2000-02-21
BR9807457A (pt) 2000-04-25
IS1901B (is) 2003-11-20
JP2001512477A (ja) 2001-08-21
KR20000075622A (ko) 2000-12-26
PT971920E (pt) 2002-11-29
EE04016B1 (et) 2003-04-15
NZ336878A (en) 2001-05-25
DE69805787D1 (de) 2002-07-11
HUP0000720A2 (hu) 2000-10-28
US6265415B1 (en) 2001-07-24
IS5148A (is) 1999-08-05
SK109999A3 (en) 2000-01-18
AR011134A1 (es) 2000-08-02
PL335485A1 (en) 2000-04-25
ID22218A (id) 1999-09-16
HUP0000720A3 (en) 2001-01-29
DK0971920T3 (da) 2002-09-16
NO313009B1 (no) 2002-07-29
NO994078L (no) 1999-08-24
CA2280008A1 (en) 1998-08-27
NO994078D0 (no) 1999-08-24
CZ301499A3 (cs) 2000-02-16
ES2178169T3 (es) 2002-12-16
CN1248257A (zh) 2000-03-22
AU6314798A (en) 1998-09-09
UA64741C2 (uk) 2004-03-15
AU723389B2 (en) 2000-08-24
SK283903B6 (sk) 2004-04-06
DE69805787T2 (de) 2003-01-02
TW568907B (en) 2004-01-01
ATE218569T1 (de) 2002-06-15
IL131122A0 (en) 2001-01-28
CZ291681B6 (cs) 2003-04-16
MY118822A (en) 2005-01-31
ZA981134B (en) 1998-08-25
HK1024248A1 (en) 2000-10-05
RU2193036C2 (ru) 2002-11-20

Similar Documents

Publication Publication Date Title
SE9801526D0 (sv) New compounds
SE9700661D0 (sv) New compounds
SE9704404D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
SE9802794D0 (sv) New compounds
SE0102808D0 (sv) New compounds
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
ES2150494T3 (es) Derivados sustituidos de quinolina y su utilizacion como inhibidores de la secrecion de acido gastrico.
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
TW200503702A (en) Novel imidazopyridine compound ii with therapeutic effect
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect